Literature DB >> 28533081

Patients' understanding of prescription drug label instructions in developing nations: The case of Saudi Arabia.

Khalid A Alburikan1, Ahmed AbuAlreesh2, Maha Alenazi2, Hadeel Albabtain2, Mariam Alqouzi2, Mohammed Alawaji2, Hisham S Aljadhey3.   

Abstract

BACKGROUND: Processing health-related data is challenging for patients. It is believed that low education level and low socioeconomic status are associated with prescription label misunderstanding, which may lead to poor clinical outcomes, increased adverse drug reactions, and increased health costs.
OBJECTIVES: The aim of this study was to gain a better insight into the current understanding of prescription drug labels, and to determine the main factors affecting patients' understanding of prescription labels.
METHOD: A total of 511 adult participants in 4 major hospitals in Riyadh were interviewed. The primary outcome was patient understanding of prescription labels for 5 commonly prescribed medications. Prescription label understanding was assessed using a prespecified structured interview protocol. Participants with less than a 6th-grade education level and monthly income less than 10,000 Saudi Riyal were considered to have a low education level and low monthly income, respectively. Logistic regression analysis was used to examine the cross-sectional association of socioeconomic factors with the participants' understanding of the medication label.
RESULTS: The prevalence of poor understanding of the medication labels was 38.6% among the participants. Out of those participants with poor understanding, 27.9% incorrectly understood at least 4 of the 5 labels. The degree of misunderstanding significantly worsened for older participants (P-value = 0.004), male (P-value < 0.001), with low education level (P-value = 0.002), and low monthly income (P-value = 0.012). The most common features misunderstood were duration of treatment (38.9%) and storage instructions (29.5%).
CONCLUSIONS: Prescription label misunderstanding is common among participants. More efforts should be made to improve patients' understanding by reducing the ambiguity of the prescription labels.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Education level; Health literacy; Label understanding; Medication label; Misunderstanding

Mesh:

Year:  2017        PMID: 28533081     DOI: 10.1016/j.sapharm.2017.05.004

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  6 in total

1.  Measuring the health literacy level of Arabic speaking population in Saudi Arabia using translated health literacy instruments.

Authors:  Talal M Alkhaldi; Ali A Al-Jumaili; Khalid A Alnemer; Khalid Alharbi; Elharith S Al-Akeel; Mohammed M Alharbi; Othman Alshabanah; Abdullah B Juwair; Abdullah Khoja
Journal:  Pharm Pract (Granada)       Date:  2018-01-10

2.  Health literacy among patients with poor understanding of prescription drug label instructions in Saudi Arabia.

Authors:  Ahmed AbuAlreesh; Khalid A Alburikan
Journal:  Saudi Pharm J       Date:  2019-06-10       Impact factor: 4.330

3.  Older adult and family caregiver experiences with prescription medication labels and their suggestions for label improvement.

Authors:  Yi Wen Tan; Sumithra Devi Suppiah; Alexandre Chan; Gerald Choon-Huat Koh; Wern-Ee Tang; Sarah Siew Cheng Tay; Rahul Malhotra
Journal:  Explor Res Clin Soc Pharm       Date:  2021-10-27

4.  Patient Satisfaction and Comprehension of Physician and Pharmacist Prescription in Saudi Arabia: A Cross-Sectional Study.

Authors:  Ammar K Alharbi; Arwa A Alhutayrashi; Areen N Alosaimi; Sawsan M Althubyani; Mokhtar Shatla
Journal:  Cureus       Date:  2022-07-27

5.  Determining the prevalence of symptoms and risk of obstructive sleep apnoea among old Saudis.

Authors:  Mohammad H Aljawadi; Abdullah T Khoja; Ahmed S BaHammam; Nawaf M Alyahya; Mohammed K Alkhalifah; Omar K AlGhmadi
Journal:  J Taibah Univ Med Sci       Date:  2021-01-20

6.  Readability of written medicine information materials in Arabic language: expert and consumer evaluation.

Authors:  Sinaa Al Aqeel; Norah Abanmy; Abeer Aldayel; Hend Al-Khalifa; Maha Al-Yahya; Mona Diab
Journal:  BMC Health Serv Res       Date:  2018-02-27       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.